In a lactating patient receiving dexamethasone, which antihistamine can be safely added?

Antihistamine Selection During Lactation

Chlorphenamine (chlorpheniramine) is the preferred antihistamine to add in a lactating patient, based on its long-established safety record during breastfeeding. 1

Rationale for Chlorphenamine

The British Journal of Dermatology guidelines explicitly state that chlorphenamine is often chosen by clinicians in the U.K. when antihistamine therapy is necessary because of its long safety record, particularly noting that "avoidance or caution is recommended for the others, particularly in the first trimester and during lactation." 1 This positions chlorphenamine as the most trusted option when treatment cannot be avoided.

Dosing

• 4-12 mg at night if sedation is acceptable
• Can be combined with a non-sedating antihistamine during the day if needed 1

Alternative Options

If non-sedating antihistamines are preferred:

Loratadine and Cetirizine

• Classified as FDA Pregnancy Category B drugs with no evidence of fetal harm 1
• Recent systematic review data show relative infant doses below 5% for all studied antihistamines, with loratadine specifically documented 2
• A 2026 study confirmed that second-generation antihistamines (predominantly used in breastfeeding women with allergies) were all classified as safe or fairly safe during lactation with relative infant doses below 10% 3
• Multiple sources confirm all antihistamines are considered safe during breastfeeding as minimal amounts are excreted in breast milk 4, 5

Critical Contraindication

Avoid hydroxyzine - it is the only antihistamine specifically contraindicated during early pregnancy in U.K. manufacturer guidelines, and caution is recommended during lactation 1

Clinical Approach

1. First choice: Chlorphenamine 4-12 mg (if sedation tolerable)
2. Second choice: Loratadine or cetirizine (if non-sedating preferred)
3. Avoid: Hydroxyzine

The evidence consistently supports that antihistamine exposure through breast milk is minimal, with no documented adverse effects on breastfed infants across multiple studies 2, 5. The choice between sedating and non-sedating agents should be based on the patient's daily activities and tolerance for sedation, not safety concerns about lactation.